We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pfenex to Regain Full Rights to PF582

News   Aug 09, 2016

 
Pfenex to Regain Full Rights to PF582
 
 
 

RELATED ARTICLES

Alzheimer Therapy Proven Safe for Use in Humans in Phase I Trial

News

The Alzheimer drug candidate PRI-002 has successfully completed Phase I of clinical research involving healthy volunteers. When administered daily over a period of four weeks, the active substance proved to be safe for use in humans. The next milestone will be the proof of efficacy in patients in clinical Phase II.

READ MORE

Radiotherapy System Rotates Patients in Sync With X-Ray Beam To Deliver Accurate Treatment for Brain Cancer

News

A new way to deliver radiotherapy that rotates patients in sync with the treatment beam could treat patients with brain cancer as accurately and quickly as the most advanced radiotherapy available, scientists at The Institute of Cancer Research, London show.

READ MORE

Statins’ Potential to Treat MS Unrelated to Lowering Cholesterol

News

The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS) - for reasons that might be unrelated to the drug’s intended cholesterol lowering affects, a UCL study has found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE